A Unified Family of Covariate-Adjusted Response-Adaptive Designs Based on Efficiency and Ethics
暂无分享,去创建一个
Jianhua Hu | Feifang Hu | Hongjian Zhu | F. Hu | Hongjian Zhu | Jianhua Hu
[1] Feifang Hu,et al. ST ] 1 7 O ct 2 00 6 ASYMPTOTIC PROPERTIES OF COVARIATE-ADJUSTED ADAPTIVE DESIGNS , 2006 .
[2] Feifang Hu,et al. Doubly adaptive biased coin designs with delayed responses , 2008 .
[3] W. Rosenberger,et al. Randomization in Clinical Trials: Theory and Practice , 2002 .
[4] Charles A. Baylis,et al. A Note on Probability. , 1951 .
[5] Feifang Hu,et al. Efficient randomized-adaptive designs , 2009, 0908.3435.
[6] D G Altman,et al. The hidden effect of time. , 1988, Statistics in medicine.
[7] R. Kronmal,et al. Lessons from the Stroke Prevention in Atrial Fibrillation Trials , 2003, Annals of Internal Medicine.
[8] Diane D. Liu,et al. Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center , 2009, Clinical trials.
[9] L. J. Wei,et al. Exact two-sample permutation tests based on the randomized play-the-winner rule , 1988 .
[10] William F. Rosenberger,et al. Utility of Covariate-Adjusted Response-Adaptive Randomization in Survival Trials , 2013 .
[11] L. J. Wei,et al. The Randomized Play-the-Winner Rule in Medical Trials , 1978 .
[12] B. Efron. Forcing a sequential experiment to be balanced , 1971 .
[13] T. Mok,et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. , 2009, The New England journal of medicine.
[14] W. Rosenberger,et al. COVARIATE-ADJUSTED RESPONSE-ADAPTIVE DESIGNS FOR BINARY RESPONSE , 2001, Journal of biopharmaceutical statistics.
[15] M Zelen,et al. The randomization and stratification of patients to clinical trials. , 1974, Journal of chronic diseases.
[16] Edward S. Kim,et al. Bayesian adaptive design for targeted therapy development in lung cancer — a step toward personalized medicine , 2008, Clinical trials.
[17] S. Pocock,et al. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. , 1975, Biometrics.
[18] D. Berry. Adaptive clinical trials: the promise and the caution. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] William F. Rosenberger,et al. Response‐Adaptive Randomization , 2005 .
[20] N Stallard,et al. Optimal Adaptive Designs for Binary Response Trials , 2001, Biometrics.
[21] Feifang Hu,et al. Doubly adaptive biased coin designs with heterogeneous responses , 2009 .
[22] Feifang Hu,et al. Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials , 2003 .
[23] Alessandra Giovagnoli,et al. On the Large Sample Optimality of Sequential Designs for Comparing Two or More Treatments , 2005 .
[24] William F. Rosenberger,et al. Implementing Optimal Allocation in Sequential Binary Response Experiments , 2007 .
[25] Uttam Bandyopadhyay,et al. Adaptive designs for normal responses with prognostic factors , 2001 .
[26] A. Atkinson. Optimum biased coin designs for sequential clinical trials with prognostic factors , 1982 .
[27] Alessandra Giovagnoli,et al. Compound optimal allocation for individual and collective ethics in binary clinical trials , 2010 .
[28] William F. Rosenberger,et al. Asymptotically best response-adaptive randomization procedures , 2006 .
[29] William F. Rosenberger,et al. Asymptotic Properties of Adaptive designs for Clinical Trials with delayed Response , 2002 .
[30] D. Berry,et al. Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] Diane M. Miller,et al. Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators. , 1990, Stroke.
[32] D. Taves,et al. The use of minimization in clinical trials. , 2010, Contemporary clinical trials.
[33] William F Rosenberger,et al. Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes , 2006, Biometrics.
[34] Feifang Hu. Statistical issues in trial design and personalized medicine , 2012 .
[35] Michael Woodroofe,et al. Central Limit Theorems for Doubly Adaptive Biased Coin Designs , 1995 .
[36] W F Rosenberger,et al. Analysis of time trends in adaptive designs with application to a neurophysiology experiment. , 2000, Statistics in medicine.
[37] P. McCullagh,et al. Generalized Linear Models , 1984 .
[38] H A Wendel,et al. Randomization in clinical trials. , 1978, Science.
[39] B. Freidlin,et al. Outcome--adaptive randomization: is it useful? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] J. H. Schuenemeyer,et al. Generalized Linear Models (2nd ed.) , 1992 .
[41] William F. Rosenberger,et al. Handling Covariates in the Design of Clinical Trials. , 2008, 1102.3773.
[42] Li-Xin Zhang,et al. Asymptotic properties of covariate-adjusted response-adaptive designs , 2006 .
[43] Douglas E. Faries,et al. A Case Study of an Adaptive Clinical Trial in the Treatment of Out-Patients with Depressive Disorder , 1994 .